과제정보
This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF), funded by the Ministry of Science & ICT (grant number: 2017M3A9A7050614).
참고문헌
- Rahib L, Smith BD, Aizenberg R et al (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74, 2913-2921
- Tzartzeva K, Obi J, Rich NE et al (2018) Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a metaanalysis. Gastroenterology 154, 1706-1718 https://doi.org/10.1053/j.gastro.2018.01.064
- Kang I, Kim JA, Kim J, Lee JH, Kim MJ and Ahn JK (2022) Hepatitis B virus X protein promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating SOCS1. BMB Rep 55, 220 https://doi.org/10.5483/BMBRep.2022.55.5.157
- Trevisani F', D'Intino PE, Morselli-Labate AM et al (2001) Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 34, 570-575 https://doi.org/10.1016/s0168-8278(00)00053-2
- Akinyemiju T, Abera S, Ahmed M et al (2017) The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol 3, 1683-1691 https://doi.org/10.1001/jamaoncol.2017.3055
- Jepsen P, Ott P, Andersen PK et al (2012) Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann Intern Med 156, 841-847 https://doi.org/10.7326/0003-4819-156-12-201206190-00004
- Estes C, Razavi H, Loomba R et al (2018) Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67, 123-133 https://doi.org/10.1002/hep.29466
- Sherman M (2014) Limitations of screening for hepatocellular carcinoma. Hepat Oncol 1, 161-163 https://doi.org/10.2217/hep.13.22
- Labgaa I, Villacorta-Martin C, D'Avola D et al (2018) A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma. Oncogene 37, 3740-3752 https://doi.org/10.1038/s41388-018-0206-3
- Jiang P, Chan CW, Chan KA et al (2015) Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A 112, 1317-1325
- Yin CQ, Yuan CH, Qu Z et al (2016) Liquid biopsy of hepatocellular carcinoma: circulating tumor-derived biomarkers. Dis Markers 2016, 1427849 https://doi.org/10.1155/2016/1427849
- Oh S, Jo Y, Jung S, Yoon S and Yoo KH (2020) From genome sequencing to the discovery of potential biomarkers in liver disease. BMB Rep 53, 299 https://doi.org/10.5483/BMBRep.2020.53.6.074
- Abbosh C, Birkbak NJ and Swanton C (2018) Early stage NSCLC-challenges to implementing ctDNA-based screening and MRD detection. Nat Rev Clin Oncol 15, 577-586 https://doi.org/10.1038/s41571-018-0058-3
- Stetson D, Ahmed A, Xu X et al (2019) Orthogonal comparison of four plasma NGS tests with tumor suggests technical factors are a major source of assay discordance. JCO Precis Oncol 3, 1-9
- Lee SM, Kim-Ha J, Choi WY et al (2016) Interplay of genetic and epigenetic alterations in hepatocellular carcinoma. Epigenomics 8, 993-1005 https://doi.org/10.2217/epi-2016-0027
- von Felden J, Garcia-Lezana T, Schulze K, Losic B and Villanueva A (2020) Liquid biopsy in the clinical management of hepatocellular carcinoma. Gut 69, 2025-2034 https://doi.org/10.1136/gutjnl-2019-320282
- Kang X, Sun L, Guo K et al (2010) Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LCMS/MS. J Cancer Res Clin Oncol 136, 1151-1159 https://doi.org/10.1007/s00432-010-0762-6
- Gorgannezhad L, Umer M, Islam MN, Nguyen NT and Shiddiky MJ (2018) Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies. Lab Chip 18, 1174-1196 https://doi.org/10.1039/C8LC00100F
- Herman JG, Graff JR, Myohanen SBDN, Nelkin BD and Baylin SB (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93, 9821-9826 https://doi.org/10.1073/pnas.93.18.9821
- Lan VTT, Ha NT, Uyen NQ et al (2014) Standardization of the methylation-specific PCR method for analyzing BRCA1 and ER methylation. Mol Med Rep 9, 1844-1850 https://doi.org/10.3892/mmr.2014.1990
- Wojdacz TK, Dobrovic A and Hansen LL (2008) Methylation-sensitive high-resolution melting. Nat Protoc 3, 1903-1908 https://doi.org/10.1038/nprot.2008.191